Columbia Asset Management’s Teva Pharmaceuticals TEVA Stock Holding History

Columbia Asset Management’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-6,649	Closed	-$355K	–	185
2016 Q1	$355K	Buy	6,649 +599	+10%	+$35.1K	0.13%	131
2015 Q4	$397K	Buy	6,050 +2,110	+54%	+$130K	0.16%	114
2015 Q3	$222K	Hold	3,940	–	–	0.09%	157
2015 Q2	$232K	Sell	3,940 -200	-5%	-$12.3K	0.09%	170
2015 Q1	$258K	Hold	4,140	–	–	0.1%	167
2014 Q4	$238K	Sell	4,140 -525	-11%	-$29.2K	0.09%	166
2014 Q3	$251K	Hold	4,665	–	–	0.1%	159
2014 Q2	$245K	Hold	4,665	–	–	0.1%	163
2014 Q1	$246K	Sell	4,665 -650	-12%	-$30K	0.11%	155
2013 Q4	$213K	Buy	+5,315	New	+$209K	0.09%	159

Other funds holding TEVA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Columbia Asset Management's TEVA Position: Q2 2016 in Review

Columbia Asset Management sold out of Teva Pharmaceuticals (TEVA) in Q2 2016, closing a stake of 6,649 shares — an estimated $355K sold.

Columbia Asset Management first reported a position in TEVA in Q4 2013 and held it in 10 quarters. The position peaked at $397K in Q4 2015. 813 funds tracked by Wall St. Rank hold TEVA as of Q2 2016.

Columbia Asset Management reported no remaining Teva Pharmaceuticals position as of Q2 2016 after selling out during the quarter.
Columbia Asset Management sold 6,649 Teva Pharmaceuticals shares in Q2 2016, an estimated $355K.
Columbia Asset Management first reported a position in Teva Pharmaceuticals in Q4 2013 and held it in 10 quarters.
Columbia Asset Management's Teva Pharmaceuticals position peaked at $397K in Q4 2015.
813 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2016.

Based on Columbia Asset Management's 13F filing for Q2 2016, filed 8 Aug 2016.